tirzepatide fda news commercial says that the GLP-1 shortage is over FDA approves weight-loss drug Zepbound

doi: 10.2337/db20-2216-PUB 46 BoyeKRossMModyRKonigMGelhornH

In some cases, a small snack might help stabilize your blood sugar, but always follow your healthcare providers guidance on managing such situations

But the GLP-1 boom has created an opportunity for compounders that has transformed pockets of the industry, with compounding pharmacies producing off-brand duplicates for likely millions of patients

59 Recently, the SURMOUNT-5 trial demonstrated that tirzepatide was superior to semaglutide in obese patients without diabetes with respect to reductions in body weight and waist circumference at week 72

I would presume until proven otherwise, that as in any chronic disease, you're going to be probably on it chronically